LAVA Therapeutics NV
NASDAQ:LVTX

Watchlist Manager
LAVA Therapeutics NV Logo
LAVA Therapeutics NV
NASDAQ:LVTX
Watchlist
Price: 1.74 USD Market Closed
Market Cap: 45.8m USD

Wall Street
Price Targets

LVTX Price Targets Summary
LAVA Therapeutics NV

Wall Street analysts forecast LVTX stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LVTX is 1.4 USD with a low forecast of 1.25 USD and a high forecast of 1.58 USD.

Lowest
Price Target
1.25 USD
28% Downside
Average
Price Target
1.4 USD
20% Downside
Highest
Price Target
1.58 USD
9% Downside
LAVA Therapeutics NV Competitors:
Price Targets
IONS
Ionis Pharmaceuticals Inc
5% Upside
BCAX
Bicara Therapeutics Inc
76% Upside
CRBU
Caribou Biosciences Inc
500% Upside
IMNM
Immunome Inc
33% Upside
RCUS
Arcus Biosciences Inc
39% Upside
NTRA
Natera Inc
1% Downside
ALEC
Alector Inc
71% Upside
EVAX
Evaxion Biotech A/S
100% Upside

Revenue
Forecast

Revenue Estimate
LAVA Therapeutics NV

For the last 4 years the compound annual growth rate for LAVA Therapeutics NV's revenue is 36%.

36%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Operating Income
Forecast

Operating Income Estimate
LAVA Therapeutics NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
LAVA Therapeutics NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-11%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LVTX's stock price target?
Price Target
1.4 USD

According to Wall Street analysts, the average 1-year price target for LVTX is 1.4 USD with a low forecast of 1.25 USD and a high forecast of 1.58 USD.

Back to Top